|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/20 | |||
| A61K 38/21 | |||
| A61K 47/34 |
| (11) | Patento numeris | 2552422 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11763095.4 |
| Europos patento paraiškos padavimo data | 2011-04-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2011/002335 |
| Data | 2011-04-04 |
| (87) | Numeris | WO 2011/122923 |
| Data | 2011-10-06 |
| (30) | Numeris | Data | Šalis |
| 20100030577 | 2010-04-02 | KR |
| (72) |
KIM, Dae Jin, KR
KIM, Min Young, KR
KIM, Jin Sun, KR
HONG, Sung Hee, KR
JUNG, Sung Youb, KR
KWON, Se Chang, KR
|
| (73) |
Hanmi Science Co., Ltd.,
550 Dongtangiheung-ro Dongtan-myeon Hwaseong-si, Gyeonggi-do 445-813,
KR
|
| (54) | LONG-ACTING INTERFERON BETA FORMULATION USING IMMUNOGLOBULIN FRAGMENT |
| LONG-ACTING INTERFERON BETA FORMULATION USING IMMUNOGLOBULIN FRAGMENT |